HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Pimodivir

HCID 67286591
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1629869-44-8
Standard SMILES
O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F
InChIKey
JGPXDNKSIXAZEQ-SBBZOCNPSA-N
Molecular formula
C20H19F2N5O2
Average molar mass
399.4 g/mol
Monoisotopic mass
399.15068119

Overview

Pimodivir is under investigation in clinical trial NCT02658825 (A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy Participants).

Names & identifiers

Preferred name
Pimodivir
IUPAC
(2S,3S)-3-[[5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
English name
Pimodivir
Molecular formula
C20H19F2N5O2
Molecular weight
399.39

Names & synonyms

Pimodivir1629869-44-8VX-787JNJ872Vx-787 anhydrous baseJNJ-63623872JNJ-63623872-ZCDDFC121MXC3JNJ63623872JNJ-872DTXSID801028095Bicyclo(2.2.2)octane-2-carboxylic acid, 3-((5-fluoro-2-(5-fluoro-1H-pyrrolo(2,3-b)pyridin-3-yl)-4-pyrimidinyl)amino)-, (2S,3S)-
Show more names
CS-2483VRT0928787VRT-0928787VRT 0928787Pimodivir (VX-787)
(2S,3S)-3-(5-FLUORO-2-(5-FLUORO-1H-PYRROLO(2,3-B)PYRIDIN-3-YL)PYRIMIDIN-4-YLAMINO)BICYCLO(2.2.2)OCTANE-2-CARBOXYLIC ACIDpimodivirumBicyclo[2.2.2]octane-2-carboxylic acid, 3-[[5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-4-pyrimidinyl]amino]-, (2S,3S)-RefChem:863299DTXCID601513662VX 787JNJ 63623872VX787

Database identifiers

CAS
1629869-44-8
PubChem CID
67286591
DTXSID
DTXSID801028095
ChEMBL
CHEMBL3318007

Properties

Computed structural propertiesFilling in

XLogP
3.8
Topological polar surface area
104 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
8
Rotatable bonds
4
Heavy atoms
29
Formal charge
0
Complexity
620

Physicochemical properties

Density
1.501 · 1.501±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
100 · Soluble in DMSO, not in water:100.0(Max Conc. mg/mL);250.38(Max Conc. mM)
form
A solid
pka
4.32 · 4.32±0.40(Predicted)
color
White to light yellow
InChIKey
JGPXDNKSIXAZEQ-SBBZOCNPSA-N
SMILES
C12CCC(CC1)[C@H](NC1C(F)=CN=C(C3C4=CC(F)=CN=C4NC=3)N=1)[C@H]2C(O)=O
FDA UNII
121 MXC3 · DFC121MXC3
NCI Drug Dictionary
pimodivir
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Applications · 2 items

DescriptionPimodivir is an inhibitor of influenza virus polymerase basic protein 2 (PB2; KD = i = ~1.6 μM) and inhibits the activity of Axl and calcium/calmodulin-dependent protein kinase IIβ (CaMKIIβ) by greater than 50% in a panel of 65 human and rat kinases. Pimodivir decreases the replication of seven adamantine- and neuraminidase inhibitor-resistant strains of influenza virus A (EC50s = 50) values of 0.58, 0.64, and 0.89, respectively, in a cell-based assay. Pimodivir increases survival in a mouse model of intranasal influenza A infection when administered at doses of 1, 3, and 10 mg/kg twice per day.

UsesPimodivir is an orally bioavailable azaindole inhibitor of influenza PB2.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
UNII
DFC121MXC3
Nikkaji
J3.756.550D